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Abstract
The Innovative Medicines Initiative (IMI) is making great strides in promoting patient 
and public involvement (PPI) in health research across Europe, supporting patient 
organisations to be involved in the projects that it funds. Despite this, the litera-
ture around PPI in health services and research originating from European countries 
appears less than from the United Kingdom (UK), where PPI is well established. 
Therefore, we conducted a systematic review to explore the attitudes and approaches 
to PPI across Europe. Eight scientific databases were systematically searched and 
data extracted. Data quality was assessed using a checklist based on the Guidance 
for Reporting Involvement of Patients and the Public (GRIPP2) (Staniszewska et al., 
Research, Involvement and Engagement, 3, 13, 2017) and the critical appraisal guide-
lines developed by Wright et al. (Health Expectations, 13, 359, 2010). We included all 
studies reporting PPI activity in both public and private health services and research 
institutions in the World Health Organization European region, excluding the UK, 
published in the English language from 1996 to 2018. Forty studies in total were in-
cluded in the analysis. The studies imply a growing interest and support for the idea 
of PPI in health services and, to a lesser extent, in health research. There seems to be 
a convergence of conceptualisations of PPI across Europe, with internationally signif-
icant areas of innovative work taking place in countries such as the Netherlands and 
the Scandinavian countries. However, the implementation of PPI is highly uneven, 
and PPI is not yet firmly embedded or adequately formalised in European healthcare 
systems and research, possibly due to a lack of infrastructure, guidance and support. 
In order to try to get a better understanding of what is happening on the ground, we 
are carrying out a survey with potential follow-up interviews as the next part of this 
research project. This work is currently on hold due to the COVID-19 pandemic.
K E Y W O R D S
approaches, attitudes, Europe, health research, health services, patient involvement, public 
involvement
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1  | INTRODUC TION
Patient and public involvement (PPI) is gaining recognition inter-
nationally as an important element in improving healthcare and in 
successful health services research (Brett et al., 2014). Despite this, 
PPI has been open to criticism. Notably, some of this criticism has 
originated within the patient and public community itself, for exam-
ple, Johannesen (2018) makes a distinction between patient activism 
and organisationally sponsored involvement. She has persuasively 
argued that much PPI amounts to nothing more than ‘virtue sig-
nalling’; although she acknowledges that there are people working 
within the field who are aware of these issues and are trying to coun-
ter them (Gibson, Britten, & Lynch, 2012).
To date, the UK has been a leader in publishing work on PPI 
(Staley, 2009). Less PPI literature has originated from other European 
countries, for example, Greenhalgh et al. (2019) conducted a system-
atic review of frameworks for supporting PPI. They discovered 65 
different frameworks, originating from authors in 10 different coun-
tries. Thirty-five of these frameworks originated in the UK, with the 
next nearest country, the USA, accounting for 14. The highest num-
ber originating from another European country was the Netherlands, 
with three.
Greenhalgh et al. (2019) also pointed out that a ‘one-size-fits-all’ 
approach to PPI is unlikely to be successful. They suggest that PPI prac-
titioners need to select and adapt existing frameworks to meet their 
own needs and contexts. This point seems particularly relevant when 
considering how PPI might be practised in different parts of Europe.
As part of the EU-funded COMBACTE-MAGNET initiative 
to develop new antimicrobials, our team from Bristol has been 
working to extend local experience in PPI to European colleagues 
in COMBACTE-MAGNET (Evans et al., 2017; Grier et al., 2018). 
Progress in developing PPI in this European network has been slower 
than anticipated. One possible explanation is that this may be due, at 
least in part, to different cultural attitudes and approaches to PPI in 
different European countries.
Variations in the commitment to, and character of, PPI across 
Europe were reported by Dent and Pahor (2015), which they largely 
attributed to path dependency, that is, the history of the countries’ 
health systems. They characterised the approaches to PPI in health-
care as three main types: choice (consumerist), voice (deliberative) 
and co-production (participative), all requiring that some level of 
confidence exists for any patient/public to feel sufficiently empow-
ered to engage actively (ibid). Across Europe, patient/public choice 
is probably the most widely implemented approach to PPI in health-
care (Coulter & Magee, 2003), while co-production is less evident 
(Coulter & Collins, 2011).
The National Institute for Health Research (NIHR) INVOLVE, 
the English national advisory group that supports active public in-
volvement in the NHS, public health and social care research, also 
describes three approaches to PPI,
• Consultation: asking patients/public for their views to inform 
decision-making;
• Collaboration: an ongoing partnership with patients/public to 
share decision-making; and
• User-led research: patients/public or the organisations that rep-
resent them actively control, direct and manage the research 
(INVOLVE, 2012).
There is no agreement across Europe on this terminology, but we 
will be using these definitions for the purpose of this paper, as they 
are recognised by a wide range of health researchers.
In order to explore the different attitudes and approaches to PPI 
across Europe, we undertook a systematic review, excluding the UK, 
as there is already extensive known and reviewed literature on PPI. 
It is worth noting that the inconsistency in terminology, definition 
and purpose of PPI in the literature may pose a challenge in doing a 
systematic review of PPI.
2  | AIM, OBJEC TIVES AND RESE ARCH 
QUESTIONS
The aim of this study was to systematically review the literature 
to identify the attitudes and approaches to PPI across the World 
Health Organization (WHO) European region—excluding the UK—in 
both public and private health services and research institutions.
The objectives were to:
• Identify any relevant reporting of PPI in European public and pri-
vate health services and research institutions.
• Appraise the quality of the reporting on PPI using recognised PPI 
reporting and critical appraisal tools.
What is known about this topic
• PPI is gaining recognition internationally as a crucial ele-
ment in improving healthcare and in successful health 
services research.
• There is extensive known and reviewed literature on PPI 
in the UK, but less PPI literature originating from other 
European countries.
• There are variations in the commitment to, and charac-
ter of, PPI across Europe.
What this paper adds
• PPI is very unevenly implemented across Europe, influ-
enced in part by the availability of infrastructure, guid-
ance and support.
• There appears to be a convergence of how PPI is con-
ceptualised across Europe.
• Despite having a lesser volume of papers reporting PPI 
than the UK, the attitudes and approaches to PPI across 
other European countries are remarkably similar.
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• Identify the attitudes of health services and research policy mak-
ers and practitioners towards PPI.
• Extract and synthesise the data on attitudes to PPI, the PPI ap-
proaches used and any impact of PPI in Europe.
The research questions were:
• To what extent is PPI reported in European health services and 
health services research?
• In those studies where the use of PPI in Europe has been reported, 
what is the quality of reporting?
• In those studies where the use of PPI in Europe has been reported, 
what is the range of approaches adopted?
• What is the range of attitudes shown towards PPI by health ser-
vices and research policy makers and practitioners in policy docu-
ments, commentaries and research reports?
• In those studies where the use of PPI in Europe has been reported, 
what is the impact of PPI?
3  | RESE ARCH DESIGN
3.1 | Methods
The study design and search strategy followed expert guidance on sys-
tematic reviews (Centre for Reviews & Dissemination, 2009), recent 
development and testing of a MEDLINE search filter for PPI (Rogers, 
Bethel, & Boddy, 2016) and the successful experience of conducting 
similar systematic reviews of PPI by the project principal investigator 
(DE) (Evans et al., 2017; Jones et al., 2015). The search strategy was 
based on five word groups (involvement, patients/public, approach, 
geographical location and service terms) as laid out in Table 1, and was 
informed by a university librarian skilled in systematic reviews.
All searches were carried out by a public health researcher (MB). 
A pilot search was performed in one database, MEDLINE, to test the 
search strategy and refine the search terms. The initial search strategy 
applied to MEDLINE yielded 8,851 results. Amending or removing cer-
tain search terms did not significantly reduce the number of results. 
However, retaining the original search terms and combining with the 
MeSH term ‘patient participation’ significantly reduced the number of 
results in MEDLINE to 242; there were no other relevant MeSH terms. 
We tried including variations of the term ‘patient participation’, that 
is, ‘patient involvement’ and ‘public involvement’. This combination in 
MEDLINE yielded a total of 272 results. Therefore, following the pilot 
search, we decided to keep the original search strategy and search terms.
We then proceeded to do a full search of the following eight 
scientific databases: MEDLINE, AMED, CINAHL Plus and PsycINFO 
(via EBSCO), EMBASE, ASSIA, Scopus and Cochrane. The search 
strategy was adapted to reflect the structure and parameters of each 
database. Where available, search queries included MeSH terms to 
optimise the breadth of results. ASSIA was the only other database 
that offered the use of MeSH terms. The MeSH terms ‘patient partic-
ipation’ or ‘consumer participation’ were used with non-MeSH terms 
‘patient involvement’ or ‘public involvement’, which yielded 46 hits 
in ASSIA. For databases that did not offer the use of MeSH terms, 
the terms ‘patient participation’, ‘patient involvement’ or ‘public in-
volvement’ were used as a sixth category. The combination of all six 
categories yielded four results in AMED, seven in CINAHL Plus, 28 
in EMBASE and 115 in Scopus. PsycINFO and Cochrane both yielded 
no results, regardless of the variations tried in the search strategy.
The results from each database were manually searched for the 
main reference article by Dent and Pahor (2015) to ensure sensitivity 
of the search strategy. A sample of search results was independently 
assessed for inclusion by DE and another experienced PPI researcher 
(AG) to check the validity of inclusion and exclusion decisions. Any dif-
ferences in reviewers’ assessments were resolved through discussion.
Inclusion criteria were all studies reporting PPI activity in health ser-
vices or health services research in the WHO European region, excluding 
the UK, published in the English language between 1996 and 2018.
Data from the online searches were entered into the reference 
management software, RefWorks, and duplicates excluded. Titles 
and abstracts were screened to exclude irrelevant articles. Any dif-
ferences in reviewers' assessments were resolved through discus-
sion, and in cases of disagreement, the principal investigator (DE) 
made the final decision. Figure 1 shows the flow of citations re-
viewed through the different phases of this systematic review.
Data from included articles were extracted using a specifically 
designed data extraction form, under the categories listed in Table 2.
TA B L E  1   Search terms
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3.2 | Quality assessment
A quality appraisal checklist was developed based on the Guidance 
for Reporting Involvement of Patients and the Public (GRIPP2) 
checklists (Staniszewska et al., 2017) and the critical appraisal guide-
lines developed by Wright, Foster, Amir, Elliott, and Wilson (2010). 
As per the data extraction form, we anticipated two types of arti-
cles—those that reported specifically on PPI, and those that reported 
on substantive health topics with only brief or limited reporting on 
PPI. The difficulty of assessing the quality of articles reporting PPI 
in research has previously been commented on (Brett et al., 2014; 
Staley, 2009). Since we anticipated that there would be relatively 
few reports which adhere to the GRIPP2 or Wright et al. guidelines, 
we decided not to set too demanding a quality threshold. We there-
fore included any study with a clear statement of aims, methods 
and reported results in accordance with the approach by Brett et al. 
(2014). Studies that were judged to have poor quality of PPI report-
ing were excluded from our review, and we make recommendations 
below for how studies can improve such reporting in future. Full-text 
articles were independently assessed by the research team (MB, AG 
and DE). Where any two reviewers' assessments differed, this was 
resolved through discussion, and in cases of disagreement, the prin-
cipal investigator (DE) made the final decision.
3.3 | Data synthesis
As data were mainly qualitative and descriptive, a thematic analy-
sis was undertaken (Braun & Clarke, 2006). Data extracted were 
entered into a framework and independently analysed by MB and 
AG to identify key themes relating to the research questions. Any 
variation in the two reviewers' assessments was resolved through 
discussion. The analysis attempted to categorise approaches to PPI 
into consultation, collaboration or co-production (INVOLVE, 2012; 
Staniszewska, Brett, Mockford, & Barber, 2011). From this analysis, 
we mapped out and characterised the different attitudes and ap-
proaches to PPI across the WHO European region.
3.4 | Ethical considerations
PPI in European healthcare and health services research is not a sensi-
tive subject matter. Participants shared data on their experiences of 
involvement in research rather than on their health or other more per-
sonal matters. The only potential ethical dilemma is that researchers 
do not always distinguish between reporting patient/public involve-
ment in research and participation in research as subjects providing 
data. The former does not require ethical review and approval, the 
same as when authors are simply reflecting on the PPI they undertook 
in the primary studies but without collecting further data from the 
patient/public contributors. The latter, however, does require ethical 
review and approval, as is also the case when authors report specific 
research into PPI, where patients/public involved in the primary sub-
stantive research are also the subjects of the research.
Thus, those reporting on PPI may or may not report whether 
ethical approval was required and obtained for the patient/public 
perspectives they are reporting. This therefore raises the question 
of whether articles that fail to specify whether ethical review was 
necessary or obtained, should be included in our study. Given the 
ethical uncertainty in this area, our view is that it would be unrea-
sonable to require all included studies to have obtained ethical ap-
proval. Instead, all studies included in the review should at least have 
F I G U R E  1   PRISMA flow of information 
through different phases of the systematic 
review
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some explicit consideration of ethical issues as a key quality crite-
rion, since ethical issues are omnipresent in PPI even when formal 
ethical review is not required.
3.5 | Registration
This systematic review is registered with PROSPERO: 
CRD42019123235.
3.6 | Patient and public involvement
This systematic review was undertaken as part of COMBACTE-
MAGNET Work Package 6i PPI work, which involves close collabora-
tion with our Patient and Public Involvement Panel for Antimicrobial 
Drugs (PPIPAD). The proposed review was discussed with the panel, 
and all emerging and eventual findings were presented to the panel 
for feedback and discussion.
4  | RESULTS
As shown in Figure 1, only three articles were excluded because of 
the quality of the reporting of PPI. The remaining 40 articles were 
included in our analysis (see Supplementary File 1 for a list of these 
articles). Thirty-four (85%) of the included studies reported specifi-
cally on PPI, while the other six (15%) reported on substantive health 
topics with brief or limited reporting on PPI. Supplementary File 2 
contains a summary of the characteristics of these included studies.
4.1 | Geographical spread of PPI studies
Twenty-seven (67.5%) of the included studies focused their PPI ini-
tiatives or research in single countries, mainly in Western Europe. 
Five (12.5%) studies compared PPI between countries, with four of 
them making the comparison with England or the UK. The remaining 
eight (20%) studies reported PPI conducted across Europe (n = 6) 
or globally (n = 2). Figure 2 illustrates the geographical spread of 
included studies across Europe (excluding UK) that either focused 
their PPI research in single countries or compared PPI initiatives be-
tween two or three countries.
The Netherlands had the highest number of studies reporting 
PPI (n = 9); five of these were from the same group of researchers 
based at VU University Amsterdam. The Scandinavian countries 
of Norway, Denmark and Sweden had 10 PPI-related studies be-
tween them—three of the five studies in Norway were from the 
Norwegian University of Science and Technology. Four studies fo-
cused their PPI in Italy, two in Slovenia and one each in Belgium, 
Cyprus, Finland, France, Germany, Greece, Ireland, Poland and 
Portugal.
Although specific countries were not able to be identified for the 
eight studies that had a Europe-wide or global focus of PPI, the pa-
pers were written by researchers from a similar geographical spread 
to that of the included studies, with the addition of Austria and Spain.
4.2 | Focus of PPI
4.2.1 | Geographical level
Thirty-four (85%) studies reported PPI focused at either the local or 
the national level, in equal numbers; four reported PPI at the regional 
level (two in Italy and two in Norway; a region being bigger than local 
and smaller than national), and two at the European level.
4.2.2 | Sector
Studies were analysed to see which sectors had PPI. Some studies 
reported PPI in multiple sectors. Just over half (n = 21; 52.5%) of the 
studies focused on how PPI was practiced among health service pro-
viders. PPI in the third sector, including patient groups and general 
members of the public, accounted for 45% (n = 18) of the studies. 
The other two sectors that had reported PPI were national govern-
ments (n = 8; 20%) and professional bodies (n = 5; 12.5%).
4.2.3 | Research or service focus
Thirty-one (77.5%) studies were focused on PPI in health services, 
while the remaining nine (22.5%) were focused on PPI in health re-
search. Table 3 shows how these are subcategorised by topic focus.
4.3 | Nature of patient or public groups involved
In the studies included, where relevant, it was more common (n = 22; 
55%) to involve existing groups of patients or public contributors 
(e.g. patient associations or self-help groups), than to set up new be-
spoke groups (n = 5; 12.5%).
TA B L E  2   Data extraction categories
1. Publication details: author, year, title, journal, volume, number, 
pages.
2. Article focused on PPI, or limited information on PPI as part of 
article on substantive health topic.
3. Countries or geographical region of Europe covered.
4. Study details: aims, design, ethics, participants, results.
5. PPI aims, setting, approaches, methods, theoretical basis, 
contributors, methods of assessment, impact (if reported).
6. Attitudes of population, professionals, researchers to PPI (if 
reported).
7. Attitudes of authors to PPI identified by the review team.
8. Strengths and limitations identified by the authors.
9. Strengths and limitations identified/other comments by the 
review team.
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4.4 | Approaches to PPI
Thirty-five studies (87.5%) directly or indirectly mentioned an approach 
to PPI. Not all of these approaches could be clearly categorised, but of 
those that could, six studies (17.1%) reported PPI through consultation, 
mainly to achieve consensus. Specific methods used in these consulta-
tions include advisory or sounding board groups, consensus meetings 
and the Delphi technique, that is, a systematic interactive method of 
gaining opinions from a panel of experts and/or members of the public 
over two or more rounds, usually conducted through questionnaires.
Ten studies (28.6%) used approaches to PPI that could be de-
scribed as collaboration, with a couple using the term ‘co-researchers’ 
to refer to the patients/publics involved. Examples of how collabora-
tion took place include:
• Research agenda-setting using dialogue/the Dialogue Model—all 
four of these studies were conducted in the Netherlands by VU 
University researchers. (The Dialogue Model is a validated approach 
to facilitating interaction between patients and professionals to es-
tablish shared understanding and agendas; Abma & Broerse, 2010.)
• Meetings, conferences or workshops
• Working groups, panels, hospital boards or ethics committees
Nine studies (25.7%) reported co-production. The Journal of 
Organization and Management published a special issue on Patient 
Involvement in Europe in 2015, featuring seven papers (Volume 29 
No. 5). The first paper in this series is our main reference for this re-
view, authored by Dent and Pahor, which describes the PPI model of 
choice (consumerist), voice (deliberative) and co-production (partic-
ipative). This model was the theoretical underpinning for five other 
papers in this special issue.
Two studies (5%), one Finnish and one Norwegian, based their 
PPI in health services on Tritter’s (2009) conceptual framework, 
which uses the following three dualities: (a) direct and indirect 
involvement, (b) patient involvement operating at the individual 
and collective level and (c) patient involvement being reactive 
or proactive. For context, the Nordic health system (compris-
ing Denmark, Finland, Iceland, Norway and Sweden, including 
their associated territories) is modelled on a framework that 
includes ‘public participation’ and ‘patient choice’ (Magnussen, 
Vrangbaek, & Saltman, 2009). The Nordic societies may be seen 
as ‘varieties of a common neo-corporatist model, with a strong 
and active state closely interacting with a dense network of 
civil society organisations, a high degree of coordination in la-
bour market policies and processes of wage formation, along 
with a generous welfare state’ (Engelstad, Larsen, Rogstad, & 
Steen-Johnsen, 2017). Although the Netherlands generally has 
a more liberal model—characteristics of which include support 
of a limited state, individual rights and freedom of choice, one 
Dutch study described the adoption of a neo-corporatist model 
of participation (van de Bovenkamp, Trappenburg, & Grit, 2010). 
In neo-corporatism, patient organisations are recognised by the 
state and become part of the formal decision-making structure. 
They are presented with so many opportunities for participation 
that they become overwhelmed by the demand, which leads to 
redistribution effects (ibid). Other tensions caused by neo-cor-
poratism are an increased risk of tokenism and professionalisa-
tion, the latter in turn causing tensions around empowerment 
possibilities and representativeness (ibid).
4.5 | Attitudes to PPI
Thirty-six studies (90%) discussed attitudes to PPI. The over-
arching theme seems to be that different levels of PPI ‘maturity’ 
exist across European countries. These studies suggest that the 
F I G U R E  2   Map showing the 
geographical spread of included studies 
across Europe [Colour figure can be 
viewed at wileyonlinelibrary.com]
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general attitude towards PPI is changing, whereby profession-
als, policy makers and pharmaceutical companies are becoming 
more open and accepting towards the role of active PPI. In addi-
tion, patients and the public are becoming more knowledgeable 
and self-confident. These studies also describe how the impor-
tance and value of PPI are increasingly being recognised, as evi-
denced by increased partnership working, for example, to reach 
consensus in research agenda-setting, and increased advocacy 
of patients' interests. Substantial PPI activity has been reported 
in some countries, for example, the Netherlands, Norway and 
Denmark, although the focus tends to be on PPI through patient 
organisations, which are increasing in number across Europe, 
rather than working with groups of individual patients.
Despite this seemingly positive attitude towards PPI, these 
studies report how the role of PPI remains marginal or tokenistic, 
therefore resulting in a lack of meaningful influence. They report 
on the reluctance of professionals and policy makers to allow a 
more direct or intense involvement than consultation. Established 
interests remain powerful, where professional knowledge is val-
ued over patient or public knowledge. These studies describe 
the existence of an implementation gap, where PPI is not yet 
firmly embedded or adequately formalised in European health-
care systems and research. Numerous barriers to translating PPI 
policy into practice were reported, including lack of power, or-
ganisational support, guidelines, resources and examples of good 
practice.
5  | DISCUSSION
Our aim was to explore the differing attitudes and approaches to PPI 
across Europe. The literature we found suggests that there is grow-
ing interest and support for the idea of PPI in health services and, to 
a lesser extent, in health research. However, the distribution of PPI 
in these fields is highly uneven, with evidence of specific areas of in-
novative practice developing and relatively more activity in Western 
Europe. It is important to note that relatively small groups of research-
ers account for some of this activity. For example, the Netherlands 
generated the highest number of included studies, nine in all, but the 
same team of researchers authored five of these. While we recognise 
that some studies may have been missed due to our inclusion criteria of 
English language publications only, there is also a likelihood that more 
PPI is taking place on the ground than is being written up for publica-
tion. Writing for publication may only occur when people feel that they 
have done something important enough to warrant the extra effort, or 
if there is a requirement to do so, for example, by funders.
Similarly, PPI may only occur in health research if there is a 
requirement by funders, which is certainly the case in the UK. 
The EU's Innovative Medicines Initiative (IMI) has made some im-
portant steps in this direction. IMI supports the development of 
a patient-centric approach and encourages all the projects that 
it funds to work in partnership with patients wherever possible 
(Innovative Medicines Initiative, 2016). Some of its most notable 
work around PPI includes,
Research or service 
focus Topic focus No. of studies
Health research Individual disease areas (aphasia, cancer, Lyme 
disease, mental health, neuromuscular disease, 
rheumatology)
6
Birth cohort study 1
Medical products development 1
Policy making in nine different disease areas 1
Health service Policy making, and service development or 
delivery
11
Quality management or improvement 5
Hospital quality management 3
Healthcare decision-making (macro, meso and 
micro levels)
3
Healthcare guideline development 1





Somatic and mental health care 1
Patient empowerment 1
Patient safety 1
TA B L E  3   Topic areas within health 
research or health service that had 
reported PPI
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• The European Patients' Academy on Therapeutic Innovation 
(EUPATI), which is the first IMI project led by a patient organi-
sation ‘to help patients engage in the drug development process 
and help orient research towards real-world needs’ (Innovative 
Medicines Initiative, 2016);
• Patients Active in Research and Dialogues for an Improved 
Generation of Medicine (PARADIGM); and
• Patient Preferences in Benefit-Risk Assessments during the Drug 
Life Cycle (PREFER).
It would be interesting to evaluate the impact on the implemen-
tation of PPI across Europe if IMI, and other EU research funders, 
made it compulsory to have PPI in health research.
Our systematic review found that more studies reported col-
laboration and co-production than consultation. The implemen-
tation of these more active approaches to PPI is encouraging, 
although depending on the context and nature of the study, PPI 
through consultation may sometimes be the most appropriate and 
useful approach.
Although we looked for alternative conceptualisations of PPI, 
the literature we uncovered tended, in general, to use concepts 
that would be familiar to anyone engaged with debates about PPI 
in health services and research in the UK. This is perhaps, in retro-
spect, unsurprising. There has been a rapid growth in peer-reviewed 
publications on this topic over recent years, with the emergence of 
several journals dedicated to the area. Therefore, it is understand-
able that authors in Europe would seek to engage with this literature, 
although as stated above, the academic literature may not always 
reflect practice on the ground. There were, however, some concep-
tions of PPI that were distinct. For example, the Dialogue Model 
developed by researchers in the Netherlands draws on a tradition 
of participatory research approaches; although it will be familiar to 
some UK readers, it has received relatively limited discussion in PPI 
circles.
On a more practical note, several papers reported the lack of 
structures, organisations and guidelines to support PPI and contin-
ued professional resistance to moving beyond anything more than 
a consultative approach, despite the growing advocacy of PPI in 
policy-making. Our systematic review also suggests that it is more 
common to work with existing patient organisations in Europe rather 
than with directly recruited groups of patients or members of the 
public. This may reflect a more neo-corporatist approach to PPI in 
some countries, as noted above. This practice also limits the pos-
sibility of PPI being implemented in areas of research that do not 
have existing patient organisations, like emergency care, infectious 
diseases and antimicrobial research.
Overall, despite the fact that there is a much greater volume 
of papers reporting PPI from the UK than from other European 
countries, the attitudes and approaches to PPI across Europe are 
remarkably similar. This similarity in attitudes and approaches to 
PPI is contrary to what we expected. In order to try to get a better 
picture of what is happening on the ground, we are carrying out a 
survey with potential follow-up interviews as the next part of this 
research project. This work is currently on hold due to the COVID-
19 pandemic.
5.1 | Limitations and recommendations
This was a pragmatic systematic review conducted by a small team. 
The initial plan was to also search the NIHR INVOLVE evidence li-
brary of published PPI articles, the journals Health Expectations and 
Research, Involvement and Engagement, and to follow-up on refer-
ences and citations from included studies. However, due to time and 
resource constraints, and the unexpectedly large number of records 
identified through the main search, we decided not to expand our 
search beyond the eight databases. We also recognise that limiting 
the review to articles published in English may miss some studies 
published in other European languages. For these reasons, we are 
aware that potentially relevant studies may have been missed and 
accept that we may not have a complete picture of the attitudes and 
approaches to PPI across Europe.
Only nine of the 40 papers included in our review used a quanti-
tative study design, or a mixed methods study design that included 
a quantitative element. Since PPI is not a specific intervention, but 
rather a collection of approaches, it cannot be easily turned into a 
standardised protocol with agreed outcomes that can be reliably 
quantified. The fact that most of the studies included in our review 
were qualitative did not hamper our ability to answer our research 
questions. To improve the quality of the PPI evidence base, it is im-
portant that publications contribute to the conceptual or theory 
development of PPI. We recommend that papers report any concep-
tual or theoretical models, or influences, used in their study. We also 
advocate for patients and members of the public to be involved in 
the development and/or management of research studies to improve 
their quality.
6  | CONCLUSIONS
This systematic review suggests that PPI in Europe is very une-
ven in its implementation. In some parts of Europe, PPI seems to 
be less well established, at least in terms of available infrastruc-
ture, guidance and support compared to others. Particular areas 
of activity appear to be driven by the interests and commitment 
of particular academics. Where interest and commitment are 
lacking, PPI is less likely to develop. However, there appears to 
be a convergence of approaches to conceptualising PPI across 
Europe, with internationally significant areas of innovative 
work taking place in countries such as the Netherlands and the 
Scandinavian countries. We anticipate that if EU funders make 
PPI in health research a requirement rather than a recommen-
dation, it will drive the practice of PPI and make a greater im-
pact across Europe. In the meantime, more research is needed 
to further improve our understanding of the attitudes and ap-
proaches to PPI in Europe.
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7  | GLOSSARY
COMBACTE-MAGNET Combatting bacterial 




GRIPP Guidance for Reporting 
Involvement of Patients and 
the Public
IMI Innovative Medicines Initiative
MeSH Medical Subject Headings, the 
National Library of Medicine 
controlled vocabulary 
thesaurus used for indexing 
articles for PubMed
NHS National Health Service
NIHR National Institute for Health 
Research
INVOLVE NIHR advisory group 
supporting active public 
involvement in the NHS, 
public health and social care 
research
PPI Patient and public involvement
WHO World Health Organization
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